BIIB080 marks the first antisense oligonucleotide targeting tau to enter clinical development for the treatment of Alzheimer ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback